Rinsho Shinkeigaku (Clinical Neurology)

Symposium 09

Vasculitic neuropathy: novel classification, diagnosis and treatment

Takashi Kanda, M.D.1)

1)Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine

The international standard of nomenclature and classification in vasculitis, CHCC 1994,was revised as CHCC 2012. In the first part of this review article I briefly summarized the CHCC 2012 and pointed out the changes in this revision, especially on the disorders related to vasculitic neuropathy. Notable changes include the introduction of new terms such as granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis. In the second part, I mentioned the tips for the diagnosis and treatment of vasculitic neuropathy. Because most of the vasculitic neuropathy patients require rigorous, long-standing immunosuppressive therapy, the accurate diagnosis based on the pathological detection of vasculitic changes is mandatory. In this regard, the value of sural nerve biopsy is still not ignorable. In the treatment of vascultic neuropathy, there are no controlled treatment trials and clinical practice is guided by experience from case series and indirectly by analogy with systemic vasculitis. Although combined therapy using prednisolone and cyclophosphamide is usually recommended by experts, tailor-made treatment regimen based on the conditions of each patient would produce the best outcome in vasculitic neuropathy.
Full Text of this Article in Japanese PDF (262K)

(CLINICA NEUROL, 54: 1050|1052, 2014)
key words: vasculitic neuropathy, CHCC2012, multiple mononeuropathy, nerve biopsy, blood-nerve barrier

(Received: 22-May-14)